Pacer Advisors Inc. Has $3.74 Million Holdings in Axon Enterprise, Inc $AXON

Pacer Advisors Inc. cut its position in Axon Enterprise, Inc (NASDAQ:AXON) by 95.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,816 shares of the biotechnology company’s stock after selling 178,124 shares during the quarter. Pacer Advisors Inc.’s holdings in Axon Enterprise were worth $3,744,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV bought a new position in shares of Axon Enterprise in the fourth quarter worth about $28,000. Sound Income Strategies LLC grew its holdings in shares of Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the last quarter. Camelot Portfolios LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at approximately $30,000. AlphaCentric Advisors LLC acquired a new position in Axon Enterprise during the 4th quarter worth approximately $34,000. Finally, Darwin Wealth Management LLC acquired a new position in Axon Enterprise during the 2nd quarter worth approximately $37,000. Institutional investors own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Piper Sandler lifted their price target on Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a research note on Thursday. Citizens Jmp reiterated a “market outperform” rating and set a $700.00 target price on shares of Axon Enterprise in a research report on Thursday, June 25th. JPMorgan Chase & Co. boosted their target price on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Finally, Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $730.92.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported second-quarter revenue of $904 million, up 35% year over year and ahead of expectations. Annual recurring revenue rose 39% to $1.6 billion, while net revenue retention reached 126%. Axon Q2 revenue release
• Positive Sentiment: Management raised its full-year 2026 revenue-growth outlook to 32%-34% and maintained its adjusted EBITDA margin outlook at 25.5%. Growth was supported by record bookings, international expansion, AI Era adoption and Dedrone counter-drone demand. Q2 earnings call highlights
• Positive Sentiment: AI Era revenue grew nearly 700%, Platform Solutions revenue increased 123% to $150 million, and Dedrone revenue exceeded $100 million, indicating strong momentum in Axon’s newer growth businesses.
• Positive Sentiment: UBS raised its price target from $440 to $600 while retaining a Neutral rating. William Blair also reiterated a Buy rating, citing recurring-revenue growth, counter-drone momentum and the expanding AI platform. William Blair Buy rating
• Neutral Sentiment: Chief Product and Technology Officer Jeffrey Kunins received 29,531 restricted stock units under a three-year executive plan, an ordinary retention and compensation award with limited immediate financial impact.
• Negative Sentiment: Quarterly earnings of $1.88 per share were below some analyst estimates, and earnings declined from $2.12 a year earlier. Software gross margin fell to 71.3% from 75.6% as professional services, memory costs and investments in new products pressured profitability. Reuters margin report
• Negative Sentiment: Free cash flow turned negative, adding to concerns that rapid expansion and inventory growth could weigh on near-term returns. Analysts and valuation reviews also describe AXON as expensive on discounted cash flow measures, increasing the stock’s sensitivity to any slowdown or margin disappointment.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $522.46 on Friday. The firm’s 50-day moving average price is $511.35 and its 200-day moving average price is $473.91. Axon Enterprise, Inc has a 1-year low of $339.01 and a 1-year high of $885.00. The firm has a market capitalization of $42.11 billion, a P/E ratio of 216.79, a P/E/G ratio of 12.43 and a beta of 1.39. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.93%. The business’s revenue was up 35.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.12 EPS. Equities research analysts anticipate that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $400.00, for a total value of $800,000.00. Following the transaction, the insider owned 52,813 shares in the company, valued at approximately $21,125,200. This represents a 3.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total value of $10,000,000.00. Following the completion of the sale, the chief executive officer directly owned 3,060,997 shares of the company’s stock, valued at $1,530,498,500. This trade represents a 0.65% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 58,989 shares of company stock worth $30,527,983 in the last quarter. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.